121934 -

The identifier is most commonly associated with a highly cited scientific review regarding microalgae-based wastewater treatment , published in the journal Bioresource Technology in 2019.

: Reviews the design and operation of these treatment systems and highlights current limitations. 121934

: It serves as the JapicCTI identifier ( 121934 ) for a study funded by Chugai Pharmaceutical. This trial reviewed the effectiveness of emicizumab , a subcutaneous treatment that significantly decreased bleeding rates in hemophilia A patients. The identifier is most commonly associated with a

: It explores how different microalgae strains can remove and recover nutrients (like nitrogen and phosphorus) from various types of wastewater. Key Findings : 121934